Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2003
11/13/2003US20030211102 Immunogens for treatment of neoplastic and infectious disease
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211100 Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
11/13/2003US20030211099 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2
11/13/2003US20030211098 Pretreatment of animal with antibodies to sensitize animal; controlling dosage
11/13/2003US20030211097 Epidermal growth factor; antitumor, anticancer agents
11/13/2003US20030211096 Detection of genes which amplification genome cells; anticancer, antitumor agent
11/13/2003US20030211092 Genetic engineering; gene expression; culture product
11/13/2003US20030211091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2003US20030211078 Therapy for restenosis; antiischemic agents; antitumor agents; anticancer agents; complexing
11/13/2003US20030211075 Mixture of sensitizer and tissue factor
11/13/2003US20030211038 Calibration sensitive toxicity to radioimmunotherapy; administering radioactive antibodies; measurement bone marrow
11/13/2003US20030209491 Immobilization; affinity separation of antibodies; medical diagnosis
11/13/2003CA2485098A1 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003CA2484930A1 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries
11/13/2003CA2484420A1 Antibodies specific for human cd22 and their therapeutic and diagnostic uses
11/13/2003CA2484182A1 Novel antibody binding tcr and tirc7 and its use in therapy and diagnosis
11/13/2003CA2484155A1 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003CA2484121A1 Antibodies that specifically bind to chemokine beta-4
11/13/2003CA2483958A1 Pregnancy detection
11/13/2003CA2483912A1 Alcam and alcam modulators
11/13/2003CA2483909A1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003CA2483552A1 Calicheamicin derivative-carrier conjugates
11/13/2003CA2482411A1 Antibody fragments specific for human carncinoembryonic antigen (cea)
11/13/2003CA2480777A1 Methods of using cytokine antagonists to treat hiv infection and aids
11/13/2003CA2480008A1 Use of il-13 receptor subunit alpha 2 as an anti-cancer vaccine
11/12/2003EP1361439A1 Screening for peptides inhibiting PP1c binding to Bcl-2, BCL-Xl and BCL-W proteins
11/12/2003EP1361272A1 Neuritin, a neurogene
11/12/2003EP1361271A2 Isolated nonapeptide derived from MAGE-3 gene and presented by HLA-A1, and uses thereof
11/12/2003EP1361267A2 Mesenchymal stem cells and their use
11/12/2003EP1361229A2 Use of Tyrosine Kinase (PYK2) to produce antibodies
11/12/2003EP1360962A2 Interferon tau composition and methods of use
11/12/2003EP1360314A2 Chemically defined medium for cultured mammalian cells
11/12/2003EP1360304A2 Enzymes
11/12/2003EP1360297A2 Ragweed allergens
11/12/2003EP1360295A2 Molecules for desease detection and treatment
11/12/2003EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
11/12/2003EP1360291A2 Human polynucleotides and polypeptides encoded thereby
11/12/2003EP1360288A2 Focused libraries of genetic packages
11/12/2003EP1360287A1 Methods of modifying eukaryotic cells
11/12/2003EP1360282A2 Degradation and detection of tse infectivity
11/12/2003EP1360281A2 Regulation of human wee1-like serine/threonine protein kinase
11/12/2003EP1360279A2 Novel form of the phgpx protein as a diagnostic marker for male infertility
11/12/2003EP1360208A1 Induvidualized anti-cancer antibodies
11/12/2003EP1360207A2 Protein arrays
11/12/2003EP1360203A1 Antibodies to non-functional p 2 x 7 receptor diagnosis and treatment of cancers and other conditions
11/12/2003EP1360199A2 Treatment involving dkk-1 or antagonists thereof
11/12/2003EP1360198A2 Novel polypeptides and nucleic acids encoded thereby
11/12/2003EP1360197A2 Histidine phosphatase interacting protein with 240kd
11/12/2003EP1359932A2 Tip39 polypeptides
11/12/2003EP1051187B1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
11/12/2003EP0994904B1 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
11/12/2003EP0882067B1 Methods of treating vascular disease with tnf antagonists
11/12/2003EP0817650B1 Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
11/12/2003EP0741515B1 Transgenic production of antibodies in milk
11/12/2003CN1455813A Human myeloma cell line
11/12/2003CN1455781A Discrimination between GnRH-Ôàáand GnRH-Ôàí"
11/12/2003CN1455680A MUCl extracellular domain and cancer treatment compositions and methods derived therefrom
11/12/2003CN1454902A Mitochondria creatinekinase antibody
11/12/2003CN1454901A Gynaecological anti-infective specificity IgY and its combined preparation
11/12/2003CN1127568C Fibroblast growth factor homologs
11/12/2003CN1127517C Trophic fuctors for central nervous system
11/12/2003CN1127516C Novel polypeptides
11/12/2003CN1127352C CCK antibodies used to improve feed efficiency
11/12/2003CN1127351C Method for inducing antigen-specific T cell tolerance
11/11/2003USRE38313 4 immunoglobulin type extracellular domains having arginine residues substituted by glutamic acid; immunosuppressants; preventing specific binding to major histocompatibility complex
11/11/2003US6647446 Method and system for using a new bus identifier resulting from a bus topology change
11/11/2003US6646243 Fixing biopolymers to substrate; obtain substrate, incubate with nucleotide sequences, expose to activator, recover product
11/11/2003US6646109 Antibody that binds specifically; blocked by nicotine
11/11/2003US6646108 Process for isolating IgG and IgA
11/11/2003US6645937 Methods using persephin and related growth factors
11/11/2003US6645935 Synthesis of glycoconjugates of the lewis Y epitope and uses thereof
11/11/2003US6645933 Polypeptide that binds extracellular domain of human Flt4 receptor tyrosine kinase; genetic engineering; endothelial cell growth factors and genes
11/11/2003US6645775 Insulin-like growth factor agonist molecules
11/11/2003US6645753 Polynucleotides; antisense agents; MAP-kinases; nucleotide sequences; use of polypeptides to identify agents modulating signal transduction leading to cell proliferation, differen-tiation, survival and treatment of such conditions (cancer)
11/11/2003US6645751 Nucleic acid isolated from Tetrahymena which codes for a triterpenoid cyclase, its production, and use
11/11/2003US6645748 Mitosis; kinetochores; immunoassay; spindle; kits; Xenopus; use to demonstrate Centromere-Associated Protein-E (CENP-E) role in mitosis and identify modulators of CENP-E activity for therapeutic, diagnostic or bioagricultural applications
11/11/2003US6645740 Nucleic acids encodings equine GM-CSF
11/11/2003US6645738 DNA molecules encoding the melanocortin 5 receptor protein from rhesus monkey
11/11/2003US6645734 Diagnosis of Alzheimer's disease
11/11/2003US6645730 Viable, biologically pure exfoliated fecal colonocytes isolated at normal ambient temperature
11/11/2003US6645729 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample
11/11/2003US6645727 Immunoglobulin mixture for use in the isolation of preferential stem cells
11/11/2003US6645723 Method for determining cytokine receptor activation by the use of an antibody
11/11/2003US6645509 Treating the thinning of the epidermis with said polypeptide
11/11/2003US6645494 An antibody, or a binding fragment thereof, specific for human CD40L antigen conjugated to a Type I ribosome inactivating protein
11/11/2003US6645493 Composition containing anti-MIF antibody
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/11/2003US6645491 Method for treating inflammatory conditions using an antibody to MIP-3α
11/11/2003US6645484 Endothelial cell transmembrane tyrosine kinase ligand
11/11/2003CA2259594C Subunit respiratory syncytial virus vaccine preparation
11/11/2003CA2210294C Immunogenic compositions containing recombinant attenuated poxviruses expressing htlv antigens
11/11/2003CA2116774C Expression in e. coli antibody fragments having at least a cysteine present as a free thiol. use for the production of bifunctional f(ab') 2 antibodies
11/11/2003CA2056279C Cell-free receptor binding assays, the production and use thereof
11/06/2003WO2003091733A1 Method of judging the onset risk of arteriosclerosis and arteriosclerotic complication
11/06/2003WO2003091437A1 Chimeric camp factors for vaccination against streptococcus infection
11/06/2003WO2003091431A1 Methylotroph producing mammalian type sugar chain
11/06/2003WO2003091415A2 Fluorobodies and chromobodies: binding ligands with intrinsic fluorescence and color
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
1 ... 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 ... 1494